Sarepta Therapeutics, Inc. (SRPT)
USD 54.87
(-6.39%)
USD 54.87
(-6.39%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 2.4 Billion USD | -12.33% |
| 2022 | 2.74 Billion USD | 23.58% |
| 2021 | 2.21 Billion USD | -0.13% |
| 2020 | 2.22 Billion USD | 121.27% |
| 2019 | 1 Billion USD | 64.75% |
| 2018 | 609.79 Million USD | 17.55% |
| 2017 | 518.74 Million USD | 493.44% |
| 2016 | 87.41 Million USD | 4.77% |
| 2015 | 83.43 Million USD | 76.1% |
| 2014 | 47.38 Million USD | 6.77% |
| 2013 | 44.37 Million USD | -45.43% |
| 2012 | 81.31 Million USD | 248.22% |
| 2011 | 23.35 Million USD | -52.14% |
| 2010 | 48.79 Million USD | 34.06% |
| 2009 | 36.39 Million USD | 271.25% |
| 2008 | 9.8 Million USD | -20.01% |
| 2007 | 12.25 Million USD | 288.98% |
| 2006 | 3.15 Million USD | 14.66% |
| 2005 | 2.74 Million USD | 22.15% |
| 2004 | 2.24 Million USD | -40.03% |
| 2003 | 3.75 Million USD | -26.77% |
| 2002 | 5.12 Million USD | 56.11% |
| 2001 | 3.28 Million USD | 90.45% |
| 2000 | 1.72 Million USD | 72.28% |
| 1999 | 1 Million USD | -16.67% |
| 1998 | 1.2 Million USD | 140.0% |
| 1997 | 500 Thousand USD | -85.29% |
| 1996 | 3.4 Million USD | 1033.33% |
| 1995 | 300 Thousand USD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q1 | 2.26 Billion USD | -5.91% |
| 2024 Q2 | 2.34 Billion USD | 3.71% |
| 2023 Q2 | 2.38 Billion USD | 1.6% |
| 2023 FY | 2.4 Billion USD | -12.33% |
| 2023 Q4 | 2.4 Billion USD | 2.55% |
| 2023 Q1 | 2.34 Billion USD | -14.45% |
| 2023 Q3 | 2.34 Billion USD | -1.64% |
| 2022 Q1 | 2.19 Billion USD | -0.93% |
| 2022 Q2 | 2.27 Billion USD | 3.23% |
| 2022 Q3 | 2.72 Billion USD | 20.04% |
| 2022 Q4 | 2.74 Billion USD | 0.66% |
| 2022 FY | 2.74 Billion USD | 23.58% |
| 2021 Q1 | 2.22 Billion USD | 0.31% |
| 2021 FY | 2.21 Billion USD | -0.13% |
| 2021 Q2 | 2.27 Billion USD | 1.98% |
| 2021 Q3 | 2.19 Billion USD | -3.57% |
| 2021 Q4 | 2.21 Billion USD | 1.24% |
| 2020 Q3 | 1.88 Billion USD | 2.63% |
| 2020 FY | 2.22 Billion USD | 121.27% |
| 2020 Q1 | 1.8 Billion USD | 79.42% |
| 2020 Q2 | 1.84 Billion USD | 2.09% |
| 2020 Q4 | 2.22 Billion USD | 17.7% |
| 2019 Q3 | 707.26 Million USD | 9.05% |
| 2019 Q2 | 648.58 Million USD | 5.4% |
| 2019 Q1 | 615.33 Million USD | 0.91% |
| 2019 Q4 | 1 Billion USD | 42.04% |
| 2019 FY | 1 Billion USD | 64.75% |
| 2018 Q4 | 609.79 Million USD | 12.29% |
| 2018 Q2 | 548.11 Million USD | 4.7% |
| 2018 FY | 609.79 Million USD | 17.55% |
| 2018 Q3 | 543.05 Million USD | -0.92% |
| 2018 Q1 | 523.52 Million USD | 0.92% |
| 2017 Q4 | 518.74 Million USD | 403.03% |
| 2017 Q2 | 72.36 Million USD | -12.17% |
| 2017 Q3 | 103.12 Million USD | 42.5% |
| 2017 Q1 | 82.39 Million USD | -5.75% |
| 2017 FY | 518.74 Million USD | 493.44% |
| 2016 Q4 | 87.41 Million USD | 11.09% |
| 2016 Q2 | 82.6 Million USD | 11.03% |
| 2016 Q3 | 78.68 Million USD | -4.75% |
| 2016 Q1 | 74.4 Million USD | -10.83% |
| 2016 FY | 87.41 Million USD | 4.77% |
| 2015 Q4 | 83.43 Million USD | 35.63% |
| 2015 Q3 | 61.51 Million USD | -7.26% |
| 2015 Q2 | 66.33 Million USD | 58.13% |
| 2015 Q1 | 41.94 Million USD | -11.46% |
| 2015 FY | 83.43 Million USD | 76.1% |
| 2014 Q2 | 37.38 Million USD | -19.47% |
| 2014 Q4 | 47.38 Million USD | 44.21% |
| 2014 FY | 47.38 Million USD | 6.77% |
| 2014 Q1 | 46.42 Million USD | 4.62% |
| 2014 Q3 | 32.85 Million USD | -12.13% |
| 2013 Q4 | 44.37 Million USD | -22.82% |
| 2013 FY | 44.37 Million USD | -45.43% |
| 2013 Q3 | 57.49 Million USD | -39.36% |
| 2013 Q2 | 94.81 Million USD | -10.6% |
| 2013 Q1 | 106.05 Million USD | 30.43% |
| 2012 FY | 81.31 Million USD | 248.22% |
| 2012 Q1 | 32.62 Million USD | 39.72% |
| 2012 Q3 | 57.64 Million USD | 194.11% |
| 2012 Q4 | 81.31 Million USD | 41.05% |
| 2012 Q2 | 19.6 Million USD | -39.92% |
| 2011 FY | 23.35 Million USD | -52.14% |
| 2011 Q2 | 39.78 Million USD | -13.72% |
| 2011 Q3 | 29.33 Million USD | -26.27% |
| 2011 Q4 | 23.35 Million USD | -20.39% |
| 2011 Q1 | 46.11 Million USD | -5.5% |
| 2010 Q3 | 46.69 Million USD | 16.09% |
| 2010 Q4 | 48.79 Million USD | 4.49% |
| 2010 FY | 48.79 Million USD | 34.06% |
| 2010 Q1 | 29.35 Million USD | -19.36% |
| 2010 Q2 | 40.22 Million USD | 37.05% |
| 2009 Q2 | 28.82 Million USD | 104.07% |
| 2009 FY | 36.39 Million USD | 271.25% |
| 2009 Q1 | 14.12 Million USD | 44.09% |
| 2009 Q4 | 36.39 Million USD | -20.22% |
| 2009 Q3 | 45.61 Million USD | 58.24% |
| 2008 Q4 | 9.8 Million USD | -25.59% |
| 2008 Q1 | 14.69 Million USD | 19.89% |
| 2008 FY | 9.8 Million USD | -20.01% |
| 2008 Q2 | 11.33 Million USD | -22.86% |
| 2008 Q3 | 13.17 Million USD | 16.24% |
| 2007 FY | 12.25 Million USD | 288.98% |
| 2007 Q4 | 12.25 Million USD | 5.3% |
| 2007 Q3 | 11.63 Million USD | 66.43% |
| 2007 Q1 | 4.34 Million USD | 37.96% |
| 2007 Q2 | 6.99 Million USD | 60.89% |
| 2006 Q4 | 3.15 Million USD | 44.34% |
| 2006 Q1 | 2.2 Million USD | -19.58% |
| 2006 Q3 | 2.18 Million USD | -3.62% |
| 2006 FY | 3.15 Million USD | 14.66% |
| 2006 Q2 | 2.26 Million USD | 2.49% |
| 2005 Q4 | 2.74 Million USD | 8.93% |
| 2005 Q3 | 2.52 Million USD | 30.93% |
| 2005 Q2 | 1.92 Million USD | -15.42% |
| 2005 Q1 | 2.27 Million USD | 1.26% |
| 2005 FY | 2.74 Million USD | 22.15% |
| 2004 FY | 2.24 Million USD | -40.03% |
| 2004 Q4 | 2.24 Million USD | 66.71% |
| 2004 Q3 | 1.34 Million USD | -37.73% |
| 2004 Q2 | 2.16 Million USD | -21.21% |
| 2004 Q1 | 2.75 Million USD | -26.68% |
| 2003 Q3 | 2.3 Million USD | 78.12% |
| 2003 Q2 | 1.29 Million USD | -19.98% |
| 2003 Q1 | 1.61 Million USD | -68.37% |
| 2003 FY | 3.75 Million USD | -26.77% |
| 2003 Q4 | 3.75 Million USD | 62.46% |
| 2002 FY | 5.12 Million USD | 56.11% |
| 2002 Q3 | 4.91 Million USD | 24.28% |
| 2002 Q4 | 5.12 Million USD | 4.2% |
| 2002 Q2 | 3.95 Million USD | -16.2% |
| 2002 Q1 | 4.71 Million USD | 43.85% |
| 2001 Q2 | 1.61 Million USD | -0.23% |
| 2001 Q3 | 1.58 Million USD | -2.02% |
| 2001 Q4 | 3.28 Million USD | 107.45% |
| 2001 FY | 3.28 Million USD | 90.45% |
| 2001 Q1 | 1.61 Million USD | -6.09% |
| 2000 Q1 | 766.97 Thousand USD | -23.3% |
| 2000 Q3 | 1.31 Million USD | 19.17% |
| 2000 Q4 | 1.72 Million USD | 30.88% |
| 2000 FY | 1.72 Million USD | 72.28% |
| 2000 Q2 | 1.1 Million USD | 44.02% |
| 1999 Q3 | 700 Thousand USD | 75.0% |
| 1999 FY | 1 Million USD | -16.67% |
| 1999 Q1 | 700 Thousand USD | -41.67% |
| 1999 Q2 | 400 Thousand USD | -42.86% |
| 1999 Q4 | 1 Million USD | 42.86% |
| 1998 Q4 | 1.2 Million USD | 0.0% |
| 1998 Q3 | 1.2 Million USD | 200.0% |
| 1998 Q1 | 500 Thousand USD | 0.0% |
| 1998 FY | 1.2 Million USD | 140.0% |
| 1998 Q2 | 400 Thousand USD | -20.0% |
| 1997 Q1 | 3.5 Million USD | 1066.67% |
| 1997 Q4 | 500 Thousand USD | -37.5% |
| 1997 Q2 | 900 Thousand USD | -74.29% |
| 1997 Q3 | 800 Thousand USD | -11.11% |
| 1997 FY | 500 Thousand USD | -85.29% |
| 1996 Q4 | 300 Thousand USD | 0.0% |
| 1996 FY | 3.4 Million USD | 1033.33% |
| 1995 FY | 300 Thousand USD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| AbCellera Biologics Inc. | 335.77 Million USD | -616.322% |
| Alkermes plc | 933.53 Million USD | -157.648% |
| Agenus Inc. | 462.29 Million USD | -420.282% |
| Alnylam Pharmaceuticals, Inc. | 4.05 Billion USD | 40.619% |
| Aptorum Group Limited | 5.25 Million USD | -45655.352% |
| Ardelyx, Inc. | 130.76 Million USD | -1739.388% |
| Arrowhead Pharmaceuticals, Inc. | 478.39 Million USD | -402.778% |
| Bicycle Therapeutics plc | 224.41 Million USD | -971.796% |
| BioXcel Therapeutics, Inc. | 130.21 Million USD | -1747.2% |
| ChromaDex Corporation | 26.5 Million USD | -8973.634% |
| Chimerix, Inc. | 19.74 Million USD | -12081.509% |
| Corbus Pharmaceuticals Holdings, Inc. | 35.17 Million USD | -6737.511% |
| Caribou Biosciences, Inc. | 72.56 Million USD | -3214.508% |
| CRISPR Therapeutics AG | 346.76 Million USD | -593.616% |
| Precision BioSciences, Inc. | 140.92 Million USD | -1606.812% |
| Dyadic International, Inc. | 2.34 Million USD | -102659.403% |
| Eton Pharmaceuticals, Inc. | 16.26 Million USD | -14689.639% |
| Fortress Biotech, Inc. | 165.93 Million USD | -1349.472% |
| Lantern Pharma Inc. | 2.73 Million USD | -87692.634% |
| HOOKIPA Pharma Inc. | 71.48 Million USD | -3264.912% |
| Inhibikase Therapeutics, Inc. | 3.52 Million USD | -68061.701% |
| Incyte Corporation | 1.59 Billion USD | -51.057% |
| IO Biotech, Inc. | 17.55 Million USD | -13600.382% |
| Jaguar Health, Inc. | 45.86 Million USD | -5144.057% |
| Novavax, Inc. | 2.57 Billion USD | 6.493% |
| Janux Therapeutics, Inc. | 36.05 Million USD | -6570.473% |
| Opthea Limited | 264.6 Million USD | -809.005% |
| Ligand Pharmaceuticals Incorporated | 130.7 Million USD | -1740.176% |
| ContextLogic Inc. | 206 Million USD | -1067.592% |
| MiMedx Group, Inc. | 96.33 Million USD | -2396.874% |
| Pyxis Oncology, Inc. | 48.02 Million USD | -4908.619% |
| TransCode Therapeutics, Inc. | 3.52 Million USD | -68058.572% |
| NextCure, Inc. | 14.99 Million USD | -15938.134% |
| Ocuphire Pharma, Inc. | 4.04 Million USD | -59406.16% |
| Oncternal Therapeutics, Inc. | 6.67 Million USD | -35922.75% |
| Outlook Therapeutics, Inc. | 46.73 Million USD | -5046.107% |
| Vaxcyte, Inc. | 167.44 Million USD | -1336.401% |
| PDS Biotechnology Corporation | 33.25 Million USD | -7131.815% |
| Madrigal Pharmaceuticals, Inc. | 235.21 Million USD | -922.575% |
| Pharming Group N.V. | 244.07 Million USD | -885.459% |
| Pieris Pharmaceuticals, Inc. | 11.92 Million USD | -20074.794% |
| Avidity Biosciences, Inc. | 127.79 Million USD | -1782.166% |
| Reviva Pharmaceuticals Holdings, Inc. | 6.6 Million USD | -36302.867% |
| Reviva Pharmaceuticals Holdings, Inc. | 6.6 Million USD | -36302.867% |
| Sangamo Therapeutics, Inc. | 82.43 Million USD | -2817.811% |
| Sol-Gel Technologies Ltd. | 6.64 Million USD | -36107.12% |
| Acelyrin, Inc. | 86.35 Million USD | -2685.357% |
| Salarius Pharmaceuticals, Inc. | 1.29 Million USD | -185026.47% |
| SELLAS Life Sciences Group, Inc. | 14.37 Million USD | -16627.443% |
| Summit Therapeutics Inc. | 125.25 Million USD | -1820.243% |
| Sensei Biotherapeutics, Inc. | 9.47 Million USD | -25274.396% |
| Senti Biosciences, Inc. | 52.57 Million USD | -4475.22% |
| Stoke Therapeutics, Inc. | 68.77 Million USD | -3397.156% |
| Syros Pharmaceuticals, Inc. | 151.51 Million USD | -1487.491% |
| Alaunos Therapeutics, Inc. | 1.95 Million USD | -122867.229% |
| Telomir Pharmaceuticals, Inc. Common Stock | 1.33 Million USD | -179991.632% |
| Entrada Therapeutics, Inc. | 226.83 Million USD | -960.361% |
| VistaGen Therapeutics, Inc. | 9.36 Million USD | -25577.794% |
| Wave Life Sciences Ltd. | 227.44 Million USD | -957.504% |
| Sorrento Therapeutics, Inc. | 494.5 Million USD | -386.389% |
| TRACON Pharmaceuticals, Inc. | 10.91 Million USD | -21938.107% |
| Barinthus Biotherapeutics plc | 27.51 Million USD | -8642.827% |
| Psyence Biomedical Ltd. | 12.1 Million USD | -19770.292% |
| Phathom Pharmaceuticals, Inc. | 486.6 Million USD | -394.294% |
| Immix Biopharma, Inc. | 3.72 Million USD | -64525.987% |
| Keros Therapeutics, Inc. | 37.81 Million USD | -6261.047% |
| MEI Pharma, Inc. | 8.35 Million USD | -28688.019% |
| Windtree Therapeutics, Inc. | 29.01 Million USD | -8189.64% |
| Xeris Biopharma Holdings, Inc. | 347.58 Million USD | -591.996% |
| Rigel Pharmaceuticals, Inc. | 145.86 Million USD | -1548.903% |
| Fortress Biotech, Inc. | 165.93 Million USD | -1349.472% |
| Precigen, Inc. | 41.64 Million USD | -5675.716% |
| Clearside Biomedical, Inc. | 49.93 Million USD | -4717.222% |
| AlloVir, Inc. | 45.01 Million USD | -5243.194% |
| C4 Therapeutics, Inc. | 130.33 Million USD | -1745.4% |
| Fate Therapeutics, Inc. | 137.8 Million USD | -1645.456% |
| ImmuCell Corporation | 18.81 Million USD | -12683.608% |
| IDEAYA Biosciences, Inc. | 28.22 Million USD | -8421.36% |
| Onconetix, Inc. | 23.18 Million USD | -10275.957% |
| PureTech Health plc | 125.58 Million USD | -1815.258% |
| VYNE Therapeutics Inc. | 8.95 Million USD | -26774.179% |
| Elevation Oncology, Inc. | 34.28 Million USD | -6916.04% |
| Kintara Therapeutics, Inc. | 2.44 Million USD | -98273.783% |
| Seer, Inc. | 39.36 Million USD | -6010.095% |
| Verrica Pharmaceuticals Inc. | 61.83 Million USD | -3789.832% |
| Innoviva, Inc. | 568.55 Million USD | -323.046% |
| Aadi Bioscience, Inc. | 27.22 Million USD | -8733.697% |
| ESSA Pharma Inc. | 3.49 Million USD | -68718.03% |
| GlycoMimetics, Inc. | 6.9 Million USD | -34748.062% |
| GT Biopharma, Inc. | 6.63 Million USD | -36161.707% |
| Inhibrx Biosciences, Inc. | 264.39 Million USD | -809.731% |
| Akebia Therapeutics, Inc. | 272.28 Million USD | -783.347% |
| Catalyst Pharmaceuticals, Inc. | 84.02 Million USD | -2762.494% |
| Longboard Pharmaceuticals, Inc. | 9.77 Million USD | -24508.543% |
| Orchestra BioMed Holdings, Inc. | 27.16 Million USD | -8752.88% |
| Alzamend Neuro, Inc. | 3.22 Million USD | -74463.182% |
| Rocket Pharmaceuticals, Inc. | 73.76 Million USD | -3160.589% |
| Aptose Biosciences Inc. | 15.8 Million USD | -15114.653% |
| ZyVersa Therapeutics, Inc. | 11.03 Million USD | -21687.205% |
| Soligenix, Inc. | 7.27 Million USD | -32962.141% |
| Century Therapeutics, Inc. | 175.94 Million USD | -1267.071% |
| Kura Oncology, Inc. | 51.66 Million USD | -4555.722% |
| TScan Therapeutics, Inc. | 121.28 Million USD | -1883.179% |
| Intensity Therapeutics, Inc. | 4.13 Million USD | -58095.959% |
| Ocean Biomedical, Inc. | 6.61 Million USD | -36266.673% |
| CytomX Therapeutics, Inc. | 252.59 Million USD | -852.2% |
| Autolus Therapeutics plc | 263.9 Million USD | -811.396% |
| Mineralys Therapeutics, Inc. | 10.48 Million USD | -22846.375% |
| EyePoint Pharmaceuticals, Inc. | 88.86 Million USD | -2606.743% |
| Eterna Therapeutics Inc. | 46.89 Million USD | -5028.551% |
| Adaptive Biotechnologies Corporation | 352.85 Million USD | -581.649% |
| GRI Bio, Inc. | 2.69 Million USD | -89082.017% |
| Xenetic Biosciences, Inc. | 809.58 Thousand USD | -296995.302% |
| Tenaya Therapeutics, Inc. | 31.09 Million USD | -7636.126% |
| IGM Biosciences, Inc. | 220.17 Million USD | -992.412% |
| INmune Bio, Inc. | 18.86 Million USD | -12651.771% |
| Heron Therapeutics, Inc. | 256.47 Million USD | -837.792% |
| SAB Biotherapeutics, Inc. | 26.64 Million USD | -8928.061% |
| Pasithea Therapeutics Corp. | 2.71 Million USD | -88379.756% |
| Entero Therapeutics, Inc. | 3.28 Million USD | -73224.511% |
| Milestone Pharmaceuticals Inc. | 58.45 Million USD | -4014.685% |
| X4 Pharmaceuticals, Inc. | 96.15 Million USD | -2401.314% |
| Atara Biotherapeutics, Inc. | 264.73 Million USD | -808.546% |
| Coherus BioSciences, Inc. | 823.02 Million USD | -192.242% |
| Verastem, Inc. | 71.18 Million USD | -3278.857% |
| Abeona Therapeutics Inc. | 49.17 Million USD | -4791.083% |
| Pliant Therapeutics, Inc. | 38.57 Million USD | -6134.743% |
| Tonix Pharmaceuticals Holding Corp. | 48.93 Million USD | -4815.472% |
| Histogen Inc. | 5.69 Million USD | -42119.396% |
| Aprea Therapeutics, Inc. | 4.38 Million USD | -54743.95% |
| Surrozen, Inc. | 8.14 Million USD | -29430.252% |
| Organovo Holdings, Inc. | 2.74 Million USD | -87426.892% |
| Lixte Biotechnology Holdings, Inc. | 313.85 Thousand USD | -766246.246% |
| Ovid Therapeutics Inc. | 56.22 Million USD | -4177.509% |
| Panbela Therapeutics, Inc. | 16.51 Million USD | -14466.612% |
| CASI Pharmaceuticals, Inc. | 51.1 Million USD | -4606.649% |
| Cadrenal Therapeutics, Inc. Common Stock | 826.87 Thousand USD | -290783.023% |
| Centessa Pharmaceuticals plc | 126.72 Million USD | -1797.999% |
| Hepion Pharmaceuticals, Inc. | 10.81 Million USD | -22142.743% |
| Arcturus Therapeutics Holdings Inc. | 150.88 Million USD | -1494.045% |
| BioRestorative Therapies, Inc. | 2.6 Million USD | -92148.59% |
| Apollomics, Inc. | 14.15 Million USD | -16894.552% |
| Amarin Corporation plc | 279.58 Million USD | -760.283% |
| Mesoblast Limited | 188.79 Million USD | -1173.975% |
| Turnstone Biologics Corp. | 14.14 Million USD | -16900.558% |
| Kymera Therapeutics, Inc. | 180.78 Million USD | -1230.42% |
| Synaptogenix, Inc. | 5.52 Million USD | -43398.553% |
| Tiziana Life Sciences Ltd | 6.64 Million USD | -36079.889% |
| Aurinia Pharmaceuticals Inc. | 170.1 Million USD | -1313.948% |
| BriaCell Therapeutics Corp. | 8.55 Million USD | -28007.804% |
| Monopar Therapeutics Inc. | 1.75 Million USD | -136764.037% |
| Exelixis, Inc. | 678.44 Million USD | -254.522% |
| Better Therapeutics, Inc. | 23.84 Million USD | -9988.243% |
| Nurix Therapeutics, Inc. | 164.04 Million USD | -1366.198% |
| Apellis Pharmaceuticals, Inc. | 594.2 Million USD | -304.78% |
| NLS Pharmaceutics AG | 10.68 Million USD | -22420.534% |
| Dermata Therapeutics, Inc. | 1.62 Million USD | -148040.878% |
| Aridis Pharmaceuticals, Inc. | 38.92 Million USD | -6078.845% |
| Gritstone bio, Inc. | 125.91 Million USD | -1810.148% |
| Jasper Therapeutics, Inc. | 14.67 Million USD | -16288.928% |
| TNF Pharmaceuticals, Inc. | 5.08 Million USD | -47166.954% |
| Avid Bioservices, Inc. | 275.66 Million USD | -772.513% |
| Insmed Incorporated | 1.66 Billion USD | -44.74% |
| Virpax Pharmaceuticals, Inc. | 7.69 Million USD | -31161.132% |
| MediWound Ltd. | 27.18 Million USD | -8747.019% |
| OmniAb, Inc. | 87.4 Million USD | -2651.99% |
| Alector, Inc. | 487.66 Million USD | -393.211% |
| Seres Therapeutics, Inc. | 403.45 Million USD | -496.159% |
| Checkpoint Therapeutics, Inc. | 18.42 Million USD | -12954.214% |
| Viracta Therapeutics, Inc. | 38.37 Million USD | -6168.05% |
| Zai Lab Limited | 240.17 Million USD | -901.444% |
| Revance Therapeutics, Inc. | 630.05 Million USD | -281.749% |
| Aura Biosciences, Inc. | 29.22 Million USD | -8129.51% |
| Lyell Immunopharma, Inc. | 95.07 Million USD | -2429.78% |
| Immunic, Inc. | 25.36 Million USD | -9381.39% |
| Tarsus Pharmaceuticals, Inc. | 69.23 Million USD | -3373.972% |
| Veracyte, Inc. | 93.71 Million USD | -2466.437% |
| InMed Pharmaceuticals Inc. | 2.61 Million USD | -91819.739% |
| FibroGen, Inc. | 585.72 Million USD | -310.641% |
| SeaStar Medical Holding Corporation | 17.38 Million USD | -13736.731% |
| Adial Pharmaceuticals, Inc. | 653.07 Thousand USD | -368193.889% |
| Sonnet BioTherapeutics Holdings, Inc. | 5.65 Million USD | -42429.518% |
| Jazz Pharmaceuticals plc | 7.65 Billion USD | 68.585% |
| Cyclacel Pharmaceuticals, Inc. | 8.19 Million USD | -29239.339% |
| Amylyx Pharmaceuticals, Inc. | 84.02 Million USD | -2762.63% |
| TG Therapeutics, Inc. | 169.08 Million USD | -1322.503% |
| Galecto, Inc. | 5.89 Million USD | -40694.42% |
| Calithera Biosciences, Inc. | 8.28 Million USD | -28934.754% |
| Fortrea Holdings Inc. | 2.61 Billion USD | 8.141% |
| KalVista Pharmaceuticals, Inc. | 28.82 Million USD | -8245.15% |
| Aptevo Therapeutics Inc. | 12.62 Million USD | -18957.436% |
| XBiotech Inc. | 8.39 Million USD | -28544.028% |
| Jasper Therapeutics, Inc. | 14.67 Million USD | -16288.928% |
| Lyra Therapeutics, Inc. | 53.18 Million USD | -4422.826% |
| Foghorn Therapeutics Inc. | 363.1 Million USD | -562.407% |
| Y-mAbs Therapeutics, Inc. | 26.88 Million USD | -8846.73% |
| Theravance Biopharma, Inc. | 169 Million USD | -1323.185% |
| Ultragenyx Pharmaceutical Inc. | 1.21 Billion USD | -97.865% |
| Metagenomi, Inc. Common Stock | 500.42 Million USD | -380.638% |
| Vaxxinity, Inc. | 30.94 Million USD | -7672.877% |
| BioCryst Pharmaceuticals, Inc. | 972.48 Million USD | -147.328% |
| Gain Therapeutics, Inc. | 6.03 Million USD | -39780.556% |
| Cartesian Therapeutics, Inc. | 745.23 Million USD | -222.749% |
| NexImmune, Inc. | 5.08 Million USD | -47207.814% |
| Creative Medical Technology Holdings, Inc. | 371.39 Thousand USD | -647524.625% |
| Marker Therapeutics, Inc. | 3.07 Million USD | -78123.021% |
| Regeneron Pharmaceuticals, Inc. | 7.1 Billion USD | 66.157% |
| Chemomab Therapeutics Ltd. | 5.15 Million USD | -46567.152% |
| Scopus BioPharma Inc. | 7.45 Million USD | -32165.884% |
| RAPT Therapeutics, Inc. | 26.29 Million USD | -9047.482% |
| Ainos, Inc. | 7.39 Million USD | -32428.624% |
| Pluri Inc. | 34.11 Million USD | -6951.006% |
| Prothena Corporation plc | 135.01 Million USD | -1681.434% |
| Adaptimmune Therapeutics plc | 243.1 Million USD | -889.391% |
| Celularity Inc. | 102.92 Million USD | -2236.794% |
| Rallybio Corporation | 9.43 Million USD | -25390.028% |
| Cue Biopharma, Inc. | 24.44 Million USD | -9739.39% |
| MeiraGTx Holdings plc | 319.99 Million USD | -651.658% |
| Omeros Corporation | 403.25 Million USD | -496.461% |
| Humacyte, Inc. | 114.67 Million USD | -1997.403% |
| Immunocore Holdings plc | 228.15 Million USD | -954.199% |
| Cocrystal Pharma, Inc. | 4.87 Million USD | -49238.236% |
| Cidara Therapeutics, Inc. | 76.74 Million USD | -3034.27% |
| Blueprint Medicines Corporation | 918.64 Million USD | -161.826% |
| CalciMedica, Inc. | 4.02 Million USD | -59612.984% |
| Cabaletta Bio, Inc. | 17.45 Million USD | -13682.025% |
| Marinus Pharmaceuticals, Inc. | 154.14 Million USD | -1460.395% |
| Scholar Rock Holding Corporation | 85.81 Million USD | -2702.754% |
| Sana Biotechnology, Inc. | 277.79 Million USD | -765.839% |
| Pulmatrix, Inc. | 15.96 Million USD | -14967.588% |
| Elicio Therapeutics, Inc. | 15.77 Million USD | -15149.09% |
| Vigil Neuroscience, Inc. | 24.6 Million USD | -9675.01% |
| Intellia Therapeutics, Inc. | 250.8 Million USD | -858.996% |
| Adlai Nortye Ltd. American Depositary Shares | 50.78 Million USD | -4636.027% |
| Cytokinetics, Incorporated | 1.21 Billion USD | -98.675% |
| Eloxx Pharmaceuticals, Inc. | 31.78 Million USD | -7467.69% |
| Nutriband Inc. | 1.07 Million USD | -222830.452% |
| Protara Therapeutics, Inc. | 10.63 Million USD | -22520.512% |
| Vor Biopharma Inc. | 59.1 Million USD | -3969.503% |
| Roivant Sciences Ltd. | 773.95 Million USD | -210.773% |
| Evogene Ltd. | 17.99 Million USD | -13269.867% |
| ProKidney Corp. | 29.21 Million USD | -8132.609% |
| Applied Therapeutics, Inc. | 71.97 Million USD | -3241.584% |
| Hoth Therapeutics, Inc. | 704.98 Thousand USD | -341076.879% |
| BridgeBio Pharma, Inc. | 1.88 Billion USD | -27.334% |
| CorMedix Inc. | 11.91 Million USD | -20082.365% |
| BioLineRx Ltd. | 50.7 Million USD | -4643.874% |
| Tango Therapeutics, Inc. | 149.45 Million USD | -1509.297% |
| Galectin Therapeutics Inc. | 88.44 Million USD | -2619.597% |
| Atai Life Sciences N.V. | 49.16 Million USD | -4792.476% |
| Renovaro Biosciences Inc. | 31.15 Million USD | -7620.902% |
| Aerovate Therapeutics, Inc. | 17.96 Million USD | -13290.708% |
| Zentalis Pharmaceuticals, Inc. | 124.63 Million USD | -1829.811% |
| Sagimet Biosciences Inc. | 5.65 Million USD | -42440.485% |
| MediciNova, Inc. | 3.89 Million USD | -61706.662% |
| Praxis Precision Medicines, Inc. | 18.27 Million USD | -13058.482% |
| Cardio Diagnostics Holdings, Inc. | 1.5 Million USD | -159797.184% |
| GeoVax Labs, Inc. | 3.51 Million USD | -68232.964% |
| Axsome Therapeutics, Inc. | 397.25 Million USD | -505.459% |
| Biomea Fusion, Inc. | 30.69 Million USD | -7737.208% |
| PTC Therapeutics, Inc. | 2.72 Billion USD | 11.628% |
| Mereo BioPharma Group plc | 15.96 Million USD | -14968.532% |
| Cullinan Oncology, Inc. | 31.2 Million USD | -7608.852% |
| Syndax Pharmaceuticals, Inc. | 58.68 Million USD | -3998.628% |
| Absci Corporation | 58.3 Million USD | -4025.341% |
| NRx Pharmaceuticals, Inc. | 19.04 Million USD | -12527.252% |
| 4D Molecular Therapeutics, Inc. | 32.06 Million USD | -7401.837% |
| Dyne Therapeutics, Inc. | 73.79 Million USD | -3159.573% |
| Kiniksa Pharmaceuticals, Ltd. | 87.48 Million USD | -2649.379% |
| Ventyx Biosciences, Inc. | 33.77 Million USD | -7022.413% |
| Allakos Inc. | 74.79 Million USD | -3115.861% |
| Imunon, Inc. | 8.53 Million USD | -28095.998% |
| Fulcrum Therapeutics, Inc. | 22.5 Million USD | -10589.476% |
| Corcept Therapeutics Incorporated | 114.81 Million USD | -1994.937% |
| BioAtla, Inc. | 48.98 Million USD | -4810.054% |
| NLS Pharmaceutics AG | 10.68 Million USD | -22420.534% |
| Bio-Path Holdings, Inc. | 2.77 Million USD | -86450.522% |
| Allogene Therapeutics, Inc. | 130.6 Million USD | -1741.627% |
| Larimar Therapeutics, Inc. | 14.21 Million USD | -16820.429% |
| XOMA Corporation | 145.58 Million USD | -1552.177% |
| Kezar Life Sciences, Inc. | 33.66 Million USD | -7044.628% |
| Cara Therapeutics, Inc. | 68.75 Million USD | -3398.072% |
| aTyr Pharma, Inc. | 31.59 Million USD | -7512.239% |
| Aligos Therapeutics, Inc. | 61.82 Million USD | -3790.525% |
| Akero Therapeutics, Inc. | 44.96 Million USD | -5249.136% |
| Viridian Therapeutics, Inc. | 48.4 Million USD | -4869.297% |
| Eliem Therapeutics, Inc. | 2.87 Million USD | -83706.237% |
| EyeGate Pharmaceuticals, Inc. | 8.15 Million USD | -29383.129% |
| Akari Therapeutics, Plc | 4.58 Million USD | -52370.31% |
| Tevogen Bio Holdings Inc. | 17.73 Million USD | -13463.533% |
| Halozyme Therapeutics, Inc. | 1.64 Billion USD | -45.82% |
| Lexaria Bioscience Corp. | 403.9 Thousand USD | -595391.795% |
| UroGen Pharma Ltd. | 243.52 Million USD | -887.685% |
| Sutro Biopharma, Inc. | 321.08 Million USD | -649.093% |
| ZIVO Bioscience, Inc. | 2.76 Million USD | -86997.175% |
| Orgenesis Inc. | 35.53 Million USD | -6668.648% |
| Entera Bio Ltd. | 1.37 Million USD | -174319.072% |
| GH Research PLC | 6.7 Million USD | -35793.732% |
| Lisata Therapeutics, Inc. | 6.8 Million USD | -35271.162% |
| Reneo Pharmaceuticals, Inc. | 18.82 Million USD | -12676.155% |
| Xencor, Inc. | 283.55 Million USD | -748.232% |
| 60 Degrees Pharmaceuticals, Inc. | 2.98 Million USD | -80459.304% |
| Replimune Group, Inc. | 113.21 Million USD | -2024.507% |
| Coeptis Therapeutics Holdings, Inc. | 3.75 Million USD | -63918.072% |
| Vanda Pharmaceuticals Inc. | 103.53 Million USD | -2223.229% |
| Lexaria Bioscience Corp. | 403.9 Thousand USD | -595391.795% |
| Portage Biotech Inc. | 4.45 Million USD | -53950.315% |
| Cardio Diagnostics Holdings, Inc. | 1.5 Million USD | -159797.184% |
| Olema Pharmaceuticals, Inc. | 23.05 Million USD | -10334.876% |
| OncoCyte Corporation | 49.29 Million USD | -4778.979% |
| Qualigen Therapeutics, Inc. | 4.13 Million USD | -58042.431% |
| Processa Pharmaceuticals, Inc. | 797.48 Thousand USD | -301503.418% |
| Purple Biotech Ltd. | 10 Million USD | -23940.37% |
| CollPlant Biotechnologies Ltd. | 5.78 Million USD | -41469.979% |
| scPharmaceuticals Inc. | 57.26 Million USD | -4100.484% |
| ProMIS Neurosciences, Inc. | 12.38 Million USD | -19315.845% |
| HilleVax, Inc. | 78.9 Million USD | -2948.117% |
| NeuroSense Therapeutics Ltd. | 5.05 Million USD | -47528.495% |
| Tharimmune, Inc. | 1.81 Million USD | -132416.697% |
| Genprex, Inc. | 3.25 Million USD | -73811.655% |
| Neumora Therapeutics, Inc. Common Stock | 27.11 Million USD | -8769.202% |
| Atossa Therapeutics, Inc. | 5.23 Million USD | -45836.574% |
| XTL Biopharmaceuticals Ltd. | 206 Thousand USD | -1167491.748% |
| Virios Therapeutics, Inc. | 358.54 Thousand USD | -670727.616% |
| OKYO Pharma Limited | 7.42 Million USD | -32311.924% |
| Savara Inc. | 37.19 Million USD | -6367.087% |
| Curis, Inc. | 57.61 Million USD | -4074.892% |
| Daré Bioscience, Inc. | 26.32 Million USD | -9035.026% |
| Carmell Therapeutics Corporation | 39.19 Million USD | -6035.846% |
| Titan Pharmaceuticals, Inc. | 1.44 Million USD | -166467.798% |
| Achieve Life Sciences, Inc. | 20.81 Million USD | -11453.096% |
| BeiGene, Ltd. | 2.23 Billion USD | -7.677% |
| Kiromic BioPharma, Inc. | 21.28 Million USD | -11197.612% |
| Revolution Medicines, Inc. Warrant | 262.39 Million USD | -816.641% |
| Protagonist Therapeutics, Inc. | 21.27 Million USD | -11206.003% |
| Erasca, Inc. | 78.61 Million USD | -2959.672% |
| bluebird bio, Inc. | 424.62 Million USD | -466.44% |
| Protagenic Therapeutics, Inc. | 655.25 Thousand USD | -366970.837% |
| BioMarin Pharmaceutical Inc. | 1.89 Billion USD | -27.258% |
| DBV Technologies S.A. | 42.8 Million USD | -5519.717% |
| Protagenic Therapeutics, Inc. | 655.25 Thousand USD | -366970.837% |
| Moderna, Inc. | 4.57 Billion USD | 47.392% |
| Vincerx Pharma, Inc. | 6.99 Million USD | -34285.118% |
| Fresh Tracks Therapeutics, Inc. | 1.65 Million USD | -145143.901% |
| Molecular Templates, Inc. | 31.17 Million USD | -7616.272% |
| Acrivon Therapeutics, Inc. Common Stock | 17.07 Million USD | -13990.445% |
| Travere Therapeutics, Inc. | 588.1 Million USD | -308.983% |
| Monte Rosa Therapeutics, Inc. | 124.5 Million USD | -1831.841% |
| Spruce Biosciences, Inc. | 27.43 Million USD | -8666.407% |
| Celldex Therapeutics, Inc. | 36.45 Million USD | -6497.649% |
| Cogent Biosciences, Inc. | 55.63 Million USD | -4223.248% |
| MacroGenics, Inc. | 154.2 Million USD | -1459.747% |
| RenovoRx, Inc. | 4.46 Million USD | -53756.673% |
| Adicet Bio, Inc. | 37.12 Million USD | -6379.631% |
| Prime Medicine, Inc. | 60.78 Million USD | -3857.287% |
| Aditxt, Inc. | 28.53 Million USD | -8330.1% |
| Adagene Inc. | 45.16 Million USD | -5224.937% |
| Estrella Immunopharma, Inc. | 180.7 Thousand USD | -1330960.149% |
| Quantum-Si incorporated | 26.63 Million USD | -8931.726% |
| Maravai LifeSciences Holdings, Inc. | 697.56 Million USD | -244.805% |
| Acurx Pharmaceuticals, Inc. | 3.04 Million USD | -78956.303% |
| Voyager Therapeutics, Inc. | 114.96 Million USD | -1992.222% |
| SciSparc Ltd. | 1.59 Million USD | -150698.683% |
| Vericel Corporation | 127.7 Million USD | -1783.434% |
| Revelation Biosciences, Inc. | 5.56 Million USD | -43121.65% |
| Minerva Neurosciences, Inc. | 85.35 Million USD | -2717.822% |
| Generation Bio Co. | 171.63 Million USD | -1301.409% |
| Astria Therapeutics, Inc. | 11.55 Million USD | -20724.58% |
| Black Diamond Therapeutics, Inc. | 41.83 Million USD | -5649.896% |
| Arcutis Biotherapeutics, Inc. | 252.69 Million USD | -851.824% |
| Invivyd, Inc. | 51.71 Million USD | -4551.13% |
| Relay Therapeutics, Inc. | 91.97 Million USD | -2515.044% |
| Quoin Pharmaceuticals, Ltd. | 6.5 Million USD | -36873.808% |
| Spero Therapeutics, Inc. | 75.49 Million USD | -3085.916% |
| Artelo Biosciences, Inc. | 1.02 Million USD | -235476.787% |
| 2seventy bio, Inc. | 310.12 Million USD | -675.568% |
| ADMA Biologics, Inc. | 193.97 Million USD | -1139.967% |
| Clene Inc. | 38.95 Million USD | -6075.038% |
| Capricor Therapeutics, Inc. | 36.13 Million USD | -6556.653% |
| Boundless Bio, Inc. Common Stock | 256.97 Million USD | -835.978% |
| GeoVax Labs, Inc. | 3.51 Million USD | -68232.964% |
| Recursion Pharmaceuticals, Inc. | 190.26 Million USD | -1164.165% |
| Citius Pharmaceuticals, Inc. | 12.17 Million USD | -19647.995% |
| Contineum Therapeutics, Inc. Class A Common Stock | 198.32 Million USD | -1112.795% |
| Relmada Therapeutics, Inc. | 12.19 Million USD | -19623.48% |
| Finch Therapeutics Group, Inc. | 48.11 Million USD | -4899.354% |
| ALX Oncology Holdings Inc. | 52.84 Million USD | -4451.842% |
| Vir Biotechnology, Inc. | 369.85 Million USD | -550.321% |
| Evaxion Biotech A/S | 17.61 Million USD | -13552.571% |
| Ocular Therapeutix, Inc. | 160.92 Million USD | -1394.596% |
| Verve Therapeutics, Inc. | 153.18 Million USD | -1470.143% |
| Trevena, Inc. | 48.26 Million USD | -4883.712% |
| Surrozen, Inc. | 8.14 Million USD | -29430.252% |
| Tyra Biosciences, Inc. | 21.59 Million USD | -11037.944% |
| Cingulate Inc. | 10.36 Million USD | -23114.654% |
| Galmed Pharmaceuticals Ltd. | 2.75 Million USD | -87363.236% |
| Unity Biotechnology, Inc. | 37.29 Million USD | -6349.745% |
| Tenax Therapeutics, Inc. | 3.58 Million USD | -66963.309% |
| Terns Pharmaceuticals, Inc. | 13.15 Million USD | -18190.791% |
| ACADIA Pharmaceuticals Inc. | 317.2 Million USD | -658.27% |
| Connect Biopharma Holdings Limited | 24.84 Million USD | -9579.42% |
| Clearmind Medicine Inc. | 3.61 Million USD | -66526.971% |
| Kronos Bio, Inc. | 54.2 Million USD | -4337.628% |
| Bolt Biotherapeutics, Inc. | 47.04 Million USD | -5012.852% |
| CERo Therapeutics Holdings, Inc. | 22.75 Million USD | -10467.958% |
| Viking Therapeutics, Inc. | 20.07 Million USD | -11883.653% |
| Statera Biopharma, Inc. | 22.67 Million USD | -10506.769% |
| ImmunityBio, Inc. | 1.09 Billion USD | -120.585% |
| Korro Bio, Inc. | 51.75 Million USD | -4547.625% |
| Kineta, Inc. | 7.22 Million USD | -33204.334% |
| BioVie Inc. | 9.7 Million USD | -24690.835% |
| Codexis, Inc. | 49.94 Million USD | -4715.679% |
| Celularity Inc. | 102.92 Million USD | -2236.794% |
| Crinetics Pharmaceuticals, Inc. | 96.24 Million USD | -2399.028% |
| Celcuity Inc. | 51.45 Million USD | -4574.899% |
| Virax Biolabs Group Limited | 345.19 Thousand USD | -696678.913% |
| Cibus, Inc. | 206.11 Million USD | -1066.929% |
| Eledon Pharmaceuticals, Inc. | 42.47 Million USD | -5562.717% |
| eFFECTOR Therapeutics, Inc. | 26.33 Million USD | -9031.854% |
| IN8bio, Inc. | 8.77 Million USD | -27319.505% |
| Kodiak Sciences Inc. | 213.59 Million USD | -1026.096% |
| Annexon, Inc. | 47.11 Million USD | -5004.714% |
| Adverum Biotechnologies, Inc. | 89.54 Million USD | -2586.187% |
| Assembly Biosciences, Inc. | 96.37 Million USD | -2395.786% |
| Avalo Therapeutics, Inc. | 13.68 Million USD | -17470.597% |
| Ionis Pharmaceuticals, Inc. | 2.6 Billion USD | 7.611% |
| Eyenovia, Inc. | 19.78 Million USD | -12059.782% |
| Puma Biotechnology, Inc. | 177.08 Million USD | -1258.232% |
| Conduit Pharmaceuticals Inc. | 7.68 Million USD | -31214.139% |
| Xilio Therapeutics, Inc. | 24.09 Million USD | -9880.659% |
| Arcellx, Inc. | 339.75 Million USD | -607.94% |
| Cardiff Oncology, Inc. | 11.89 Million USD | -20115.49% |
| Enanta Pharmaceuticals, Inc. | 245.54 Million USD | -879.571% |
| Regulus Therapeutics Inc. | 9.56 Million USD | -25051.511% |
| Moolec Science SA | 13.94 Million USD | -17147.598% |
| Acumen Pharmaceuticals, Inc. | 43.15 Million USD | -5473.876% |
| Geron Corporation | 146.12 Million USD | -1545.992% |
| LAVA Therapeutics N.V. | 50.53 Million USD | -4659.833% |
| Royalty Pharma plc | 6.29 Billion USD | 61.807% |
| Atea Pharmaceuticals, Inc. | 39.77 Million USD | -5946.96% |
| Greenwich LifeSciences, Inc. | 294.4 Thousand USD | -816880.293% |
| TFF Pharmaceuticals, Inc. | 2.46 Million USD | -97662.736% |
| Mersana Therapeutics, Inc. | 189.15 Million USD | -1171.564% |
| Humacyte, Inc. | 114.67 Million USD | -1997.403% |
| Structure Therapeutics Inc. | 29.05 Million USD | -8179.366% |
| 89bio, Inc. | 59.96 Million USD | -3911.205% |
| PMV Pharmaceuticals, Inc. | 26.46 Million USD | -8989.064% |
| Avenue Therapeutics, Inc. | 1.19 Million USD | -201006.94% |
| Genelux Corporation | 8.42 Million USD | -28465.784% |
| Trevi Therapeutics, Inc. | 6.85 Million USD | -34982.249% |
| Lexicon Pharmaceuticals, Inc. | 136.31 Million USD | -1664.419% |
| Notable Labs, Ltd. | 4.42 Million USD | -54231.127% |
| Liquidia Corporation | 73.13 Million USD | -3188.631% |
| Mustang Bio, Inc. | 17.61 Million USD | -13551.393% |
| Immunovant, Inc. | 48.95 Million USD | -4813.163% |
| Quantum-Si incorporated | 26.63 Million USD | -8931.726% |
| Arbutus Biopharma Corporation | 38.38 Million USD | -6166.417% |
| DiaMedica Therapeutics Inc. | 3.1 Million USD | -77413.342% |
| Vera Therapeutics, Inc. | 73.86 Million USD | -3156.44% |
| Acasti Pharma Inc. | 11.55 Million USD | -20711.967% |
| MiNK Therapeutics, Inc. | 22.6 Million USD | -10539.012% |
| Pasithea Therapeutics Corp. | 2.71 Million USD | -88379.756% |
| Xenon Pharmaceuticals Inc. | 36.87 Million USD | -6422.328% |
| Elevai Labs, Inc. Common Stock | 1.36 Million USD | -176387.003% |
| NeuroBo Pharmaceuticals, Inc. | 6.09 Million USD | -39356.02% |
| Tempest Therapeutics, Inc. | 24.83 Million USD | -9584.876% |
| Soleno Therapeutics, Inc. | 23.18 Million USD | -10274.564% |
| PepGen Inc. | 34.63 Million USD | -6845.335% |
| Moleculin Biotech, Inc. | 12.14 Million USD | -19705.986% |
| United Therapeutics Corporation | 1.18 Billion USD | -103.454% |
| Nuvectis Pharma, Inc. | 6.98 Million USD | -34339.275% |
| Solid Biosciences Inc. | 38.45 Million USD | -6154.197% |
| BriaCell Therapeutics Corp. | 8.55 Million USD | -28007.804% |
| Immuneering Corporation | 12 Million USD | -19929.713% |
| Lixte Biotechnology Holdings, Inc. | 313.85 Thousand USD | -766246.246% |
| Silo Pharma, Inc. | 1.56 Million USD | -153171.203% |
| Belite Bio, Inc | 4.21 Million USD | -57018.0% |
| XOMA Corporation | 145.58 Million USD | -1552.177% |
| ARS Pharmaceuticals, Inc. | 2.42 Million USD | -98962.562% |
| Bionomics Limited | 10.15 Million USD | -23576.593% |
| Apogee Therapeutics, Inc. | 21.49 Million USD | -11091.843% |
| Alpha Tau Medical Ltd. | 22.91 Million USD | -10397.268% |
| uniQure N.V. | 624.01 Million USD | -285.443% |
| Cassava Sciences, Inc. | 14.19 Million USD | -16844.269% |
| Estrella Immunopharma, Inc. | 180.7 Thousand USD | -1330960.149% |
| Poseida Therapeutics, Inc. | 170.18 Million USD | -1313.317% |
| Forte Biosciences, Inc. | 3.66 Million USD | -65509.356% |
| Anebulo Pharmaceuticals, Inc. | 260.58 Thousand USD | -922922.223% |
| Enlivex Therapeutics Ltd. | 6.74 Million USD | -35549.014% |
| Conduit Pharmaceuticals Inc. | 7.68 Million USD | -31214.139% |
| SeaStar Medical Holding Corporation | 17.38 Million USD | -13736.731% |
| FibroBiologics, Inc. Common Stock | 10.56 Million USD | -22659.642% |
| Altimmune, Inc. | 16.54 Million USD | -14441.074% |
| Amicus Therapeutics, Inc. | 617.7 Million USD | -289.382% |
| Alpha Tau Medical Ltd. | 22.91 Million USD | -10397.268% |
| Compugen Ltd. | 55.77 Million USD | -4212.396% |
| Peak Bio, Inc. | 20.75 Million USD | -11489.634% |
| Zevra Therapeutics, Inc. | 110.46 Million USD | -2077.416% |
| Benitec Biopharma Inc. | 4.96 Million USD | -48373.176% |
| Spyre Therapeutics, Inc. | 157.84 Million USD | -1423.817% |
| NKGen Biotech, Inc. Common Stock | 75.17 Million USD | -3099.562% |
| Zura Bio Limited | 21.29 Million USD | -11196.445% |
| PolyPid Ltd. | 17.46 Million USD | -13669.401% |
| Aileron Therapeutics, Inc. | 112.39 Million USD | -2039.911% |
| NKGen Biotech, Inc. Warrants | 75.17 Million USD | -3099.562% |
| Instil Bio, Inc. | 99.8 Million USD | -2310.035% |
| argenx SE | 444.95 Million USD | -440.563% |
| Immunome, Inc. | 28.65 Million USD | -8292.906% |
| Compass Therapeutics, Inc. | 8.33 Million USD | -28750.174% |
| Verona Pharma plc | 58.84 Million USD | -3987.692% |
| enGene Holdings Inc. Warrants | 14.47 Million USD | -16518.801% |
| Shattuck Labs, Inc. | 14.85 Million USD | -16087.085% |
| CervoMed Inc. | 2.59 Million USD | -92560.764% |
| LENZ Therapeutics, Inc. | 4.87 Million USD | -49248.359% |
| Plus Therapeutics, Inc. | 12.73 Million USD | -18785.356% |
| Dianthus Therapeutics, Inc. | 10.53 Million USD | -22730.935% |
| Moolec Science SA | 13.94 Million USD | -17147.598% |
| Enveric Biosciences, Inc. | 2.34 Million USD | -102534.303% |
| Inovio Pharmaceuticals, Inc. | 55.59 Million USD | -4226.336% |
| AnaptysBio, Inc. | 364.28 Million USD | -560.261% |
| Design Therapeutics, Inc. | 11.95 Million USD | -20017.422% |
| Leap Therapeutics, Inc. | 12.68 Million USD | -18862.78% |
| NeurAxis, Inc. | 1.91 Million USD | -125648.416% |
| Seelos Therapeutics, Inc. | 38.92 Million USD | -6078.686% |
| Lumos Pharma, Inc. | 13.33 Million USD | -17939.743% |
| Achilles Therapeutics plc | 19.08 Million USD | -12501.451% |
| enGene Holdings Inc. Common Stock | 14.47 Million USD | -16518.801% |
| 180 Life Sciences Corp. | 5.38 Million USD | -44547.219% |
| Opiant Pharmaceuticals, Inc. | 23.58 Million USD | -10096.88% |
| CERo Therapeutics Holdings, Inc. | 22.75 Million USD | -10467.958% |
| Nutriband Inc. | 1.07 Million USD | -222830.452% |
| ORIC Pharmaceuticals, Inc. | 30.59 Million USD | -7760.772% |
| CG Oncology, Inc. Common stock | 14.51 Million USD | -16475.281% |
| Fractyl Health, Inc. Common Stock | 401.27 Million USD | -499.401% |
| Rani Therapeutics Holdings, Inc. | 32.47 Million USD | -7306.889% |
| MoonLake Immunotherapeutics | 13.04 Million USD | -18332.227% |
| Palisade Bio, Inc. | 2.73 Million USD | -87714.494% |
| Tourmaline Bio, Inc. | 5.25 Million USD | -45687.912% |
| Beam Therapeutics Inc. | 478.38 Million USD | -402.783% |
| Neurogene Inc. | 36.54 Million USD | -6480.861% |
| Mirum Pharmaceuticals, Inc. | 397.95 Million USD | -504.406% |
| AEON Biopharma, Inc. | 159.88 Million USD | -1404.318% |
| CARGO Therapeutics, Inc. Common Stock | 47.65 Million USD | -4947.721% |
| Sesen Bio, Inc. | 30.98 Million USD | -7662.842% |
| Enliven Therapeutics, Inc. | 25.96 Million USD | -9164.816% |
| Kiora Pharmaceuticals, Inc. | 7.6 Million USD | -31538.656% |
| Iovance Biotherapeutics, Inc. | 195.73 Million USD | -1128.805% |
| Taysha Gene Therapies, Inc. | 192.05 Million USD | -1152.357% |
| Athira Pharma, Inc. | 30.05 Million USD | -7902.259% |
| Vaccinex, Inc. | 5.94 Million USD | -40378.61% |
| HCW Biologics Inc. | 15.05 Million USD | -15879.591% |
| XOMA Corporation | 145.58 Million USD | -1552.177% |
| Nektar Therapeutics | 267.04 Million USD | -800.683% |
| Arvinas, Inc. | 644.6 Million USD | -273.137% |
| Tevogen Bio Holdings Inc. | 17.73 Million USD | -13463.533% |
| Merus N.V. | 102.15 Million USD | -2254.592% |
| Omega Therapeutics, Inc. | 146.35 Million USD | -1543.484% |
| Quince Therapeutics, Inc. | 95.12 Million USD | -2428.636% |
| Rezolute, Inc. | 11.73 Million USD | -20398.031% |
| Clene Inc. | 38.95 Million USD | -6075.038% |
| Indaptus Therapeutics, Inc. | 2.84 Million USD | -84372.006% |
| BeyondSpring Inc. | 48.26 Million USD | -4882.989% |
| Synlogic, Inc. | 32.89 Million USD | -7211.868% |
| Allarity Therapeutics, Inc. | 14.61 Million USD | -16359.584% |
| Phio Pharmaceuticals Corp. | 1.63 Million USD | -147099.449% |
| Peak Bio, Inc. | 20.75 Million USD | -11489.634% |
| Werewolf Therapeutics, Inc. | 63.45 Million USD | -3690.225% |
| Krystal Biotech, Inc. | 39.71 Million USD | -5956.401% |
| Karyopharm Therapeutics Inc. | 376.64 Million USD | -538.597% |
| SpringWorks Therapeutics, Inc. | 99.56 Million USD | -2315.65% |
| Lipella Pharmaceuticals Inc. | 432.72 Thousand USD | -555734.177% |
| MannKind Corporation | 721.36 Million USD | -233.428% |
| Ikena Oncology, Inc. | 22.33 Million USD | -10668.923% |
| Cyclerion Therapeutics, Inc. | 2.08 Million USD | -115203.883% |
| Gyre Therapeutics, Inc. | 102.59 Million USD | -2244.516% |
| Gossamer Bio, Inc. | 249.14 Million USD | -865.39% |
| CohBar, Inc. | 1.03 Million USD | -232596.457% |
| Cognition Therapeutics, Inc. | 10.68 Million USD | -22402.002% |
| NRx Pharmaceuticals, Inc. | 19.04 Million USD | -12527.252% |
| Legend Biotech Corporation | 589.93 Million USD | -307.714% |
| Mural Oncology plc | 37.92 Million USD | -6241.592% |
| Biora Therapeutics, Inc. | 132.63 Million USD | -1713.413% |
| PaxMedica, Inc. Common Stock | 2.29 Million USD | -104688.283% |
| Disc Medicine, Inc. | 22.87 Million USD | -10414.706% |
| Champions Oncology, Inc. | 28.03 Million USD | -8479.415% |
| REGENXBIO Inc. | 262.22 Million USD | -817.232% |
| Ensysce Biosciences, Inc. | 3.35 Million USD | -71498.302% |
| Anavex Life Sciences Corp. | 12.53 Million USD | -19089.716% |
| Cellectar Biosciences, Inc. | 13.43 Million USD | -17807.28% |
| Edgewise Therapeutics, Inc. | 21.2 Million USD | -11242.792% |
| Vaxart, Inc. | 34.02 Million USD | -6969.035% |
| PharmaCyte Biotech, Inc. | 20.38 Million USD | -11696.596% |
| Aldeyra Therapeutics, Inc. | 28.53 Million USD | -8330.005% |
| Cellectis S.A. | 249.57 Million USD | -863.734% |
| Longeveron Inc. | 5.33 Million USD | -44967.248% |
| Repare Therapeutics Inc. | 41.81 Million USD | -5651.546% |
| Inozyme Pharma, Inc. | 60.36 Million USD | -3884.295% |
| Revolution Medicines, Inc. | 262.39 Million USD | -816.641% |
| Nymox Pharmaceutical Corporation | 2.1 Million USD | -114054.675% |
| Third Harmonic Bio, Inc. | 8.62 Million USD | -27783.596% |
| ArriVent BioPharma, Inc. Common Stock | 11.8 Million USD | -20281.654% |
| AN2 Therapeutics, Inc. | 14.04 Million USD | -17027.672% |
| Anixa Biosciences, Inc. | 2.15 Million USD | -111719.572% |
| Vertex Pharmaceuticals Incorporated | 5.14 Billion USD | 53.295% |
| Denali Therapeutics Inc. | 122.96 Million USD | -1856.067% |
| Revelation Biosciences, Inc. | 5.56 Million USD | -43121.65% |
| Veru Inc. | 32.81 Million USD | -7230.206% |
| Corvus Pharmaceuticals, Inc. | 6.86 Million USD | -34915.854% |
| Cingulate Inc. | 10.36 Million USD | -23114.654% |
| Passage Bio, Inc. | 39.26 Million USD | -6026.124% |
| Context Therapeutics Inc. | 4.19 Million USD | -57280.786% |
| Exicure, Inc. | 8.54 Million USD | -28034.741% |
| Day One Biopharmaceuticals, Inc. | 29.5 Million USD | -8051.142% |
| Oramed Pharmaceuticals Inc. | 10.48 Million USD | -22837.622% |
| Scinai Immunotherapeutics Ltd. | 22.04 Million USD | -10812.567% |
| Rhythm Pharmaceuticals, Inc. | 162.98 Million USD | -1375.733% |
| Nuvalent, Inc. | 31.82 Million USD | -7458.178% |
| ABVC BioPharma, Inc. | 6.36 Million USD | -37708.551% |
| Carisma Therapeutics, Inc. | 63.02 Million USD | -3716.507% |
| Unicycive Therapeutics, Inc. | 18 Million USD | -13262.439% |
| OmniAb, Inc. | 87.4 Million USD | -2651.99% |
| Anew Medical, Inc. | 8.24 Million USD | -29083.422% |
| Fennec Pharmaceuticals Inc. | 38.28 Million USD | -6181.786% |
| Lipocine Inc. | 2.63 Million USD | -91297.344% |
| Lexeo Therapeutics, Inc. Common Stock | 26.27 Million USD | -9055.142% |
| Nautilus Biotechnology, Inc. | 40.21 Million USD | -5881.396% |
| SAB Biotherapeutics, Inc. | 26.64 Million USD | -8928.061% |
| G1 Therapeutics, Inc. | 86.15 Million USD | -2691.79% |
| Bellerophon Therapeutics, Inc. | 5.4 Million USD | -44433.216% |
| Sage Therapeutics, Inc. | 82.74 Million USD | -2806.739% |
| Ocugen, Inc. | 23.98 Million USD | -9928.933% |
| Mind Medicine (MindMed) Inc. | 46.4 Million USD | -5082.923% |
| Q32 Bio Inc. | 233.12 Million USD | -931.725% |
| Brainstorm Cell Therapeutics Inc. | 9.06 Million USD | -26430.322% |
| Alumis Inc. Common Stock | 53.5 Million USD | -4395.606% |
| Equillium, Inc. | 27.95 Million USD | -8503.352% |
| Kyverna Therapeutics, Inc. | 206.59 Million USD | -1064.246% |
| Coya Therapeutics, Inc. | 5.62 Million USD | -42647.151% |
| CNS Pharmaceuticals, Inc. | 6.13 Million USD | -39118.189% |
| Galera Therapeutics, Inc. | 157.32 Million USD | -1428.825% |
| Evelo Biosciences, Inc. | 69.43 Million USD | -3364.115% |
| Comera Life Sciences Holdings, Inc. | 9.97 Million USD | -24014.603% |
| Dominari Holdings Inc. | 4.63 Million USD | -51792.967% |
| Edesa Biotech, Inc. | 1.84 Million USD | -130503.317% |
| vTv Therapeutics Inc. | 29.56 Million USD | -8034.877% |
| Bio-Techne Corporation | 744.34 Million USD | -223.137% |
| Agios Pharmaceuticals, Inc. | 126.09 Million USD | -1807.421% |
| Harmony Biosciences Holdings, Inc. | 344.45 Million USD | -598.272% |
| Prelude Therapeutics Incorporated | 40.57 Million USD | -5827.884% |
| Candel Therapeutics, Inc. | 28.95 Million USD | -8206.244% |
| iTeos Therapeutics, Inc. | 92.36 Million USD | -2504.2% |
| Nkarta, Inc. | 105.6 Million USD | -2177.688% |
| BioCardia, Inc. | 4.59 Million USD | -52301.721% |
| Iterum Therapeutics plc | 32.66 Million USD | -7264.029% |